Cite
HARVARD Citation
Ito, T. et al. (2022). Treatment with immune checkpoint inhibitors after EGFR‐TKIs in EGFR‐mutated lung cancer. Thoracic cancer. 13 (3), pp. 386-393. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ito, T. et al. (2022). Treatment with immune checkpoint inhibitors after EGFR‐TKIs in EGFR‐mutated lung cancer. Thoracic cancer. 13 (3), pp. 386-393. [Online].